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Available online 13 January 2016Very recent studies hold promise to reveal the role of stromal interaction molecule 1 (STIM1) in non-store-
operated Ca2+ entry. Here we showed that in contrast to cytoplasmic membrane redistribution as previously
noted, human umbilical vein endothelial STIM1 with a T-to-C nucleotide transition resulting in an amino acid
substitution of leucine by proline in the signal peptide sequence translocated to perinuclear membrane upon
intracellular Ca2+ depletion, ampliﬁed nucleoplasmic Ca2+ signaling through ryanodine receptor-dependent
pathway, and enhanced the subsequent cAMP responsive element binding protein activity, matrix
metalloproteinase-2 (MMP-2) gene expression, and endothelial tube forming. The abundance of mutated
STIM1 and the MMP-2 expression were higher in native human umbilical vein endothelial cells of patients
with gestational hypertension than controls and were signiﬁcantly correlated with blood pressure. These ﬁnd-
ings broaden our understanding about structure–function bias of STIM1 and offer unique insights into its appli-
cation in nucleoplasmic Ca2+, MMP-2 expression, endothelial dysfunction, and pathophysiological
mechanism(s) of gestational hypertension.





CAMP responsive element binding protein
Gene expression1. Introduction
The breakthrough discovery of STIM1 in Ca2+ inﬂux from indepen-
dent groups [1,2,3] heavily stroked the entire ﬁeld of Ca2+ signaling
[4]. Many laboratories have been focusing on this hot ﬁeld to reveal
the long-lasting mechanistic mystery of Ca2+ inﬂux [4,5,6], namely,
store-operated Ca2+ entry (SOCE). As a type I single-pass transmem-
brane protein, STIM1 is located not only in the endoplasmic
reticulum(ER) mainly [1,2,3] but also in the cytoplasmic membrane to
some extent [3,7,8,9,10]. Upon Ca2+ stores depletion, STIM1 translo-
cates from the ER into dispersed, small points underneath the cytoplas-
mic membrane to mediate SOCE. A critical function of STIM1
constitutively resident in the cytoplasmic membrane, not translocatediology, Tongji Medical College,
uhan 430030, People's Republic
. This is an open access article underfrom ER, is suggested for the regulation of the noncapacitative, arachi-
donic acid-regulated Ca2+-selective (ARC) channels activity in several
studies [8,9,11]. In addition, an antibody outwardly targeted to the N-
terminal EF hand of STIM1 restrains both Ca2+ release-activated Ca2+
(CRAC) channel activity in hematopoietic cells and SOCE in HEK293
cells, suggesting that STIM1 executes critical functions within the cyto-
plasmic membrane in the absence and presence of store depletion [10].
STIM1 translocation can occur independently of SOCE in other type of
cells [12,13]. STIM1 appears to be a far more general controller of
Ca2+ signaling than originally thought and holds diverse, and even to-
tally different, patterns of action.
Nucleoplasmic [Ca2+] ([Ca2+]N) signaling can be cytoplasmic [Ca2+]
([Ca2+]C)-dependent and -independent [14,15]. Unlike [Ca2+]C signal-
ing, the mechanism(s) underlying the regulation of [Ca2+]N remains
highlymysterious [14–22]. Several studies reported signiﬁcantly altered
functions of STIM1 resulted from a single point mutation(s) either nat-
urally occurred or artiﬁcially generated [1,3,10,23–26]. A gene
mutation(s) can thus provide a unique and valuable approach to reveal-
ing the depth of structure–function relationship for STIM1 as also forthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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mutation in human umbilical vein endothelial STIM1 and reveled its
novel functions andmechanism in the regulation of endothelial nucleo-
plasmic Ca2+ signaling.
2. Materials and methods
2.1 Cell culture
The culture of human umbilical vein endothelial cells (HUVECs)
from the umbilical cord of healthy or pregnancy-induced hypertension
puerpera was conducted under an institutional ethics committee-
approved protocol [27,28], and an informed consent was obtained
from each of these women.
2.2 Confocal imaging of nucleoplasmic/cytoplasmic Ca2+ signaling
Subcellular Ca2+ dynamics was examined on an Olympus inverted
confocal microscope (1X71) using Fluo-3, the most applicable Ca2+
dye displaying a broad dynamic scope, low degree of cellular compart-
mentalization, and a suitable apparent binding afﬁnity for Ca2+ [29].
HUVECs were loaded with Fluo-3 AM (prepared in DMSO), for 25 min
at room temperature (RT) in HEPES buffered saline (HBS) containing
NaCl 137, KCl 5.4, CaCl2 1.5, MgCl2 1.2, HEPES 20, and glucose 15 (in
mM), pH 7.40. The cells were washed thoroughly, and Fluo-3 ﬂuores-
cence was measured at the wavelength N505 nm with an excitation at
thewavelength of 488nm. The setting of confocal pinholewas to render
spatial resolutions of 400 nm in the x- and y-axes and 800 nm in the z-
axis. Two-dimensional images were generated by scanning once every
0.5 s at 150 nm per pixel, 512 pixels per line, and 256 lines per image.
The photobleaching and potential laser injury to the cells were mini-
mized by lowering the laser power to ~1% of its maximal level
(25 mW) through an acousto-optical tunable modulator/ﬁlter. [Ca2+]C
and [Ca2+]N were calibrated by the pseudo-ratio technique [30], using
the equation [Ca2+]i = (KD·R) / [((KD/[Ca2+]rest) + 1)− R], where R
was F/F0, KD of Fluo-3 was 1.1 μM, and the [Ca2+]rest was assumed to
be 100 nM based on our previous studies in these types of cells using
Ca2+ ﬂuorescent ratio indicator fura-2 [27,28]. The calibration of abso-
lute [Ca2+]N and [Ca2+]C levels can be potentially affected by nucleo-
plasmic and cytoplasmic divergences in the properties of the Ca2+
ﬂuorescent dye [31], and the relative changes of [Ca2+]N and [Ca2+]C
signal normalized for each individual cells were therefore employed
when any comparison between the alterations in [Ca2+]N and [Ca2+]C
was made.
In some experiments, InsP3R was inhibited by intracellular loading
of heparin using the established hypo-osmotic pinocytic lysis procedure
[32]. Brieﬂy, cells were incubated in M199 contain 10% polyethylene
glycol 1000, 5 mg/ml heparin, and 0.5 M sucrose at RT for 5 min. Then
the cells were exposed to hypo-osmotic media (6 parts M199 to 4
parts H2O) for 2 min before rinsing and continuous incubation in
M199 for the subsequent experiments.
2.3 Immunoﬂuorescence
The cells were washed by PBS, ﬁxed in cold methanol at−20 °C for
10min and rinsed twice by PBS, then treatedwith 0.5% Triton-PBS three
times each for 15 min. The cells were rinsed completely and then incu-
bated with a blocking solution supplemented with 0.5% bovine serum
albumin and 5%donkey serum in PBS for 40min. The cellswere incubat-
ed with primary antibodies against STIM1 (mouse anti-human, 1:200
dilute; Santa Cruz) and LAP2 (rabbit anti-human, 1:200 dilute; Santa
Cruz) at 4 °C overnight, washed with 0.2% Triton in PBS three times
each for 10 min, and probed with the required tetramethylrhodamine
isothiocyanate (TRITC)-conjugated secondary antibody for STIM1 (rab-
bit anti-mouse; Santa Cruz) and FITC-conjugated secondary antibody
for LAP2 (goat anti-rabbit; Santa Cruz) for 1 h, respectively. Cells werewashed three times with 0.2% Triton-PBS each for 10 min and treated
with 4′6-diamidino-2-phenylindole (10 μg/ml) for 15min, thenwashed
again with 0.2% Triton-PBS. In some preparations, cells were incubated
with 1 μg/ml DiOC6 (Invitrogen) for 10 min and then washed three
times with PBS. Fluorescence images were acquired using the confocal
laser scanning microscope.
Quantitative analysis of STIM1 subcellular translocation was per-
formed by estimating the increase in TRITC ﬂuorescence at the nuclear
membrane compared to the cytoplasm with Image Pro Plus 5.0
software.
2.4 Endothelial STIM1 cloning
The primers for PCR were designed according to a human STIM1 se-
quence (NM_003156). The primers of sense 5′-ATGGATGTATGCGTCC
GTCTTG-3′ and antisense: 5′-CTACTTCTTAAGAGGCTTCTTAAAGATT-3′
were synthesized and puriﬁed through PAGE by the GenScript Corpora-
tion. Touchdown PCR was conducted using LApro Taq polymerase
(GenScrip) with the following settings: an initial 5 min denaturation
at 95 °C, followed by 25 cycles of 0.5 min at 94 °C, 0.5 min at 60–50 °C
(reduced by 0.5 °C for each cycle), 1 min at 72 °C, and ﬁnally an exten-
sion of 5 min at 72 °C. The products of PCR were separated through a
1.5% agarose gel, and the PCR products of desired size were removed
from the gel, puriﬁed with the Gel Extraction Kit (GenScript), and
subcloned into the pUC57 plasmid vector (GenScript) and transformed
into DH5α cells (Invitrogen). The inserts were sequenced using primers
speciﬁc to the vector of an automated ABI 3730xl DNA sequencer. The
point mutation was originally identiﬁed and veriﬁed by sequencing in
forward and reverse directions in two separate clones and further con-
ﬁrmed in freshly isolatedHUVECs fromdifferent donors. Sequence anal-
ysis was performed using the software of Seqman from DNAstar
package (Lasergene, USA). Themutation reported here has been depos-
ited in GenBank (accession number of JX014264) and scanned against
the database, and no sequence with signiﬁcant relatedness to the new
mutation has been identiﬁed. Sequencing on nuclear DNA of the cells
did not identify the same mutation, implying the originality of the mu-
tation at gene editing level.
2.5 Construction of endothelial STIM1-GFP
Full-length mutated and wild-type STIM1 cDNA were cloned into
pLVX-AcGFP1–1 (Clontech) at BamHI/EcoRI, respectively. The successful
constructions were veriﬁed by sequencing.
2.6 Translocation of GFP-tagged protein
To determine the kinetics of STIM1 perinuclear membrane translo-
cation, the above construct of endothelial STIM1-GFP was transfected
in HUVEC on coverslips using established techniques [27,28].
A time series of images from HUVEC was taken using the laser scan-
ning confocal microscope system at various time periods up to 30 min
after treatment. After background subtraction, the ﬂuorescence intensi-
ties in a dotted area in the perinuclearmembranewere quantiﬁed using
NIH Image Software to reveal the temporal characteristics of STIM1-GFP
translocation.
2.7 Assessment of STIM1 and MMP-2 mRNA levels
Total RNA isolated from treated HUVECs was subject to real-time
PCR as previously described [27,28]. One microgram of total RNA for
each sample was used to generate cDNA using Superscript 1st Strand
System (Takara). Each RNA/primer was gently mixed with 25 μL cDNA
Synthesis Mix (Takara) and warmed for 20 min at 37 °C. The mixture
was heated at 85 °C for 5 s and then chilled on ice to terminate the reac-
tions. Real-time PCR were conducted using Sybgree1 Mix (Takara) and
speciﬁc primers for MMP-2 and GAPDH (Invitrogen) on Rotor Gene
Fig. 1. Confocal images of oscillatory translocation of endogenous STIM1 after Ca2+ store(s) depletion. (A–D) Endogenous STIM1 in resting HUVECwas labeled by tetramethylrhodamine
isothiocyanate (TRITC, A). HUVEC were co-stained with endoplasmic reticulum(ER) and nuclei as identiﬁed by DiOC6 and DAPI, respectively (B and C). Merged ﬂuorescent staining for
STIM1, nuclei, and ER shows a predominant cytosolic distribution of STIM1 in resting HUVEC (D). (E–I) HUVEC monolayers were ﬁxed at 1, 3, 10, 30, and 60 min after 1 μM
thapsigargin treatment in HBS containing 1.5 mM Ca2+, endogenous STIM1 was labeled by a primary antibody against STIM1 and secondary antibody conjugated with a
tetramethylrhodamine isothiocyanate (TRITC) (E). HUVEC were co-stained with nuclei by a monoclonal antibody against LAP2, a nuclear membrane protein, and by DAPI (F and G).
Merged ﬂuorescent staining for STIM1 and LAP2 shows a repetitive or oscillatory perinuclear membrane translocation of endogenous STIM1 at 3 and 30 min after Ca2+ store depletion
in HUVEC (H). The averaged ﬂuorescence intensity of STIM1-TRITC (E) in the cytoplasm and along perinuclear membrane areas was used to calculate the ratio of the perinuclear
membrane/cytoplasm pixel intensities. The perinuclear membrane translocation of endogenous STIM1 was repeatedly noted at 3 and 30 min in HUVEC after Ca2+ store(s) depletion
(gray), but not in the control (dark). An average of 56–69 individual cells from 4 separate HUVEC preparations were counted for each time point (*p b 0.01 vs control, I). Each of the
staining pictures represents one of four sets of separate experiments that yielded similar results.
619F. Chen et al. / Biochimica et Biophysica Acta 1863 (2016) 617–6293000 (Corbett) with 5 s at 95 °C and a 45 cycle loop: 95 °C for 5 s, 54 °C
for 30 s and 72 °C for 30 s. The standard curve for each gene was gener-
ated and used to quantify the mRNA concentration of each sample. Du-
plicatemeasurementswere conducted and theMMP-2mRNA level was
normalized by GAPDH and then expressed as a fold of the correspond-
ing control for each condition. The assessment of wild-type andmutated STIM1 mRNA abundance was performed using the ampliﬁca-
tion refractory mutation system principle [24,33] with 30 s at 95 °C
and a 50 cycle loop: 95 °C for 5 s, 56 °C for 45 s. The speciﬁc primers
and probes forwild-type andmutated STIM1were designed using a sin-
gle forward primer: AACTTGGAGCACTTTGGCTGTT, and a single TagMan
probe for both the wild-type and mutation reactions: TCCCCAGAGGAG
620 F. Chen et al. / Biochimica et Biophysica Acta 1863 (2016) 617–629CCACAGGGCAAGAC with labeling of 5′-FAM and 3′-TAMRA (Takara).
The reverse primers were TCTGGCCCTGGTGCAGGAtGA and TCTGGCCC
TGGTGCAGGAtGG for the wild-type and mutated STIM1, respectively.The 3′-ends of the reverse primers were complementary to the wild-
type or mutated STIM1 cDNA sequences, and the designated “t” was
an additional mismatch incorporated to enhance allelic discrimination.
Fig. 3. The translocation of mutated STIM1 ﬂuorescence in the nuclear membrane. Images of HUVEC expressing mutated STIM1-GFP and a representative area (white box) after the
application of thapsigargin demonstrating the time-dependent traveling of STIM1-GFP were captured and enlarged before (upper left), during (upper middle), and after (upper right)
the translocation of ﬂuorescence. Following the direction from the dark, nuclear area to nuclear membrane (NM) as indicated by the white line with arrow, the changes of ﬂuorescent
intensity along the vertical line crossing the inner edge of nuclear membrane were quantiﬁed and shown in the dark blue, red, and purple curves, respectively.
621F. Chen et al. / Biochimica et Biophysica Acta 1863 (2016) 617–6292.8 Measurement of endogenous CREB activity
An ELISA-based assay was performed to measure endogenous CREB
activities as before [27,28].
2.9 Endothelial tube formation assay
HUVECs were serum starved overnight, treated with HBS or 1 μM
histamine for 60 min and then seeded into 48-well plates pre-coated
with growth factor-reduced Matrigel (BD). The cells were cultured at
37 °C for 12 h at 37 °C, in the normal serum-containing culture medium
but without addition of extra growth factors, and endothelial tube for-
mation was visualized by phase-contrast microscopy. The tube length
was measured as the mean summed length of capillary-like structures
in 2 wells, per high-power ﬁelds (2.5×) per well and normalized as a
percentage of HBS-treated HUVECs. Duplicate measurements for each
of 6 separate experiments for each condition were performed.
2.10 Statistical analysis
Data were presented as mean± SE. Baseline parameters were com-
pared between two groups using paired and unpaired Student's t-test.
While multiple groups are involved, one-way ANOVA followed byFig. 2. Live cell ﬂuorescence imaging of subcellular translocation of STIM1-GFP. In HUVEC transf
mutated STIM1-GFP from cytoplasm under a laser scanning confocal microscope system was
STIM1-GFP (D). Images of the whole cell expressing mutated STIM1-GFP just before (t= 0) an
the time-dependent traveling of STIM1-GFP (white box) from cytoplasm to nuclear membran
the sequential windows (A). A time series of the STIM1-GFP ﬂuorescence images of the repr
nuclear membrane within the representative area were shown for mutated STIM1 in Ca2+ st
and G), respectively. Each ﬁgure represents one of at least three independent experiments witHolm-Sidak or Tukey test will be performed. The signiﬁcant difference
was considered at a level of p b 0.05.3. Results
3.1 Endogenous STIM1 translocation on Ca2+ store(s) depletion
The STIM1 immunoﬂuorescent staining appeared predominantly
within the cytoplasm, and very little was in the nucleoplasm in resting
HUVEC in HBS containing 2.0 mM Ca2+. In this resting condition when
Ca2+ stores were full, co-staining with nuclei and ER further showed
that endogenous STIM1 co-localized with ER in HUVEC (Fig. 1A–D).
These results are completely in agreement with previous reports in
other cell types [12,34,35,36].
In contrast, STIM1 staining was located predominantly in the
perinuclear membrane area (Fig. 1E–I) after a 3 min of treatment with
1 μM thapsigargin (TG) to deplete Ca2+ stores, as compared to resting
control HUVEC. In addition to nuclei identiﬁcation by DAPI, nuclei
were also simultaneously stained by a monoclonal antibody against
lamina-associated polypeptide 2 (LAP2), a nuclear membrane protein.
In this way, we validated that endogenous STIM1 indeed translocated
to perinuclear membrane area on Ca2+ store(s) depletion. To reveal
dynamics of endogenous STIM1 subcellular redistribution, STIM1ectedwith an STIM1-GFP construct, a rapid nuclear membrane translocation and sliding of
noted in Ca2+ store(s)-depleted HUVEC (A), not in unstimulated time control (C) or WT
d a representative area (yellow box) after the application of thapsigargin demonstrating
e and its subsequent sliding along the nuclear membrane were captured and enlarged in
esentative area and the ﬂuorescence intensity tracing of a dotted area(red box) on the
ore(s)-depleted HUVEC (B and E), unstimulated control (C and F) or WT STIM1-GFP (D
h the same results.
622 F. Chen et al. / Biochimica et Biophysica Acta 1863 (2016) 617–629immunoﬂuorescent staining was performed at a series of time points
after TG treatment. STIM1 stainingwas located predominantly in the cy-
toplasm at 1 min after TG treatment, aggregated mainly aroundperinuclear membrane area at 3 min, then returned back in the cyto-
plasm at 10 min, translocated at perinuclear membrane area again at
30 min, and ﬁnally located in cytoplasm at 60 min (Fig. 1E–I). Thus,
623F. Chen et al. / Biochimica et Biophysica Acta 1863 (2016) 617–629endogenous STIM1 repetitively translocates between cytoplasm and
perinuclear membrane in HUVEC after Ca2+ store(s) depletion.
To precisely determine the dynamics of endogenous STIM1 translo-
cation, the averaged STIM1 ﬂuorescence in the cytoplasm and along the
perinuclear membrane area (for both time control and TG-treated
HUVEC) was quantitatively estimated, respectively. The ratio of the
perinuclear membrane/cytoplasm pixel intensities was calculated and
plotted against the time points, quantitatively summarizing the charac-
teristics of oscillatory perinuclear membrane translocation of endoge-
nous STIM1 upon Ca2+ store(s) depletion for each time point,
respectively (56–69 individual cells from 4 separate HUVEC prepara-
tions, Fig. 1I).
3.2 Molecular cloning of an STIM1 variant
One STIM1 variant, the 44th single base mutation of CTC→ CCC that
results in a predicted substitution of the 15th amino acid of Leu by Pro
was originally identiﬁed and veriﬁed by sequencing in forward and re-
verse directions in two separate clones and further conﬁrmed in freshly
isolated HUVECs from different donors.
3.3 STIM1-GFP subcellular translocation
To individually determine and compare the translocation kinetics of
wild-type (WT) andmutated endothelial STIM1, we performed live cell
imaging of STIM1 using GFP as a tracer. Ca2+ store(s) depletion stimu-
lated a rapid translocation of mutated STIM1-GFP from the cytosol to
nuclearmembrane and the subsequent sliding along nuclearmembrane
in HUVEC (Fig. 2A). By contrast, translocation from cytosol to nuclear
membrane was not observed in WT STIM1-GFP expressed HUVEC
after Ca2+ store(s) depletion (Fig. 2D). The movement or translocation
of STIM1-GFP from the cytoplasm to cytoplasmic membrane was
noted in both mutated and wild-type STIM1-expressing HUVEC after
Ca2+ store(s) depletion. The real-time and continuous monitoring of
ﬂuorescence intensities in one dotted area in nuclear membrane re-
vealed interval or repetitive GFP translocation after Ca2+
store(s) depletion in HUVEC expressing mutated (Fig. 2B and 2E), not
WT STIM1-GFP (Fig. 2D and G) or in a time control HUVEC without
Ca2+ store(s) depletion (Fig. 2C and F).
To determine whether the translocated ﬂuorescence was genuinely
in the nuclearmembrane or just closed to it, we further performed ﬂuo-
rescence analysis more meticulously. As shown in Fig. 3, we analyzed
the change of ﬂuorescent intensity along the vertical line crossing the
inner edge of nuclear membrane of an area before, during, and after
the translocation of ﬂuorescence. We ﬁrst determined the position of
the inner edge of nuclear membrane in the area before translocation
(upper left): following thedirection from the dark, nuclear area to nucle-
ar membrane as indicated by the white arrow, the ﬂuorescent intensity
rose abruptly at the 40 pixel distance from the nuclear area without
ﬂuorescence (lower, dark blue curve). In the position from which the
ﬂuorescent intensity rose abruptly, the 40 pixel distance from the nucle-
ar area was therefore determined to be the inner edge nuclear mem-
brane. Then we analyzed the change of ﬂuorescent intensity along the
same line when translocation of ﬂuorescence occurred (upper middle):
following the direction from the dark, nuclear area to nuclear mem-
brane as indicated by the white arrow, the ﬂuorescent intensity rose
abruptly almost exactly from the 40 pixel distance (lower, red curve).
The ﬂuorescence translocations occurring at or overlapping with the
inner edge of nuclear membrane necessarily indicated that theFig. 4. Effects of STIM1 knockdown on thapsigargin-induced cytoplasmic and nucleoplasmic
nonspeciﬁc scramble shRNA (E), and STIM1 shRNA (G) were loaded with Fluo-3. [Ca2+] resp
as R1) and then the presence of 2.0 mM extracellular Ca2+ (peak as R2) were continuous
transfected HUVECs individually and the expression of GFP did not affect the Ca2+ responses.
frequent distribution were summarized in B, D, F, H for control (80 cells from 5 independent e
cells from 10 independent experiments), and STIM1 shRNA (54 cells from 10 independent e
cytoplasm by STIM1 knockdown was compared in I.ﬂuorescence was at least partly IN the nuclear membrane. After the
translocation of ﬂuorescence (upper right): following the direction
from the dark, nuclear area to nuclear membrane as indicated by the
white arrow, the ﬂuorescent intensity rose abruptly also from the 40
pixel distance (lower, purple curve). The above coincidence of ﬂuores-
cence changes from the same position before, during, and after ﬂuores-
cence translocation indicated again that the ﬂorescence was at least
partly in the nuclear membrane.
3.4 STIM1 in [Ca2+]N signaling
The depletion of Ca2+ store(s) by TG stimulated a large, transient in-
crease in both [Ca2+]C and [Ca2+]N (R1), and the subsequent application
of 2.0 mM Ca2+ evoked an additional increase in both [Ca2+]C and
[Ca2+]N (R2, Fig. 4A). The second [Ca2+] peak response in nucleoplasm
or cytoplasmwas about 100–200% of the ﬁrst one (R2/R1) in themajor-
ity of HUVEC examined (~40% and 50% for [Ca2+]N and [Ca2+]C, respec-
tively, Fig. 4B). STIM1 knockdown profoundly inhibited the second
[Ca2+] peak responses in nucleoplasm and cytoplasm (Fig. 4G). Impor-
tantly, in ~60% of STIM1-knockdown HUVEC, the [Ca2+]N (R2/R1) was
≤20% (Fig. 4H). In contrast, in only ~18% of the same HUVEC, the
[Ca2+]C(R2/R1)was ≤20% (Fig. 4H). In average, the [Ca2+] signal inhibi-
tion by STIM1 knockdown was more profound in nucleoplasm than cy-
toplasm (89.4% for [Ca2+]N, n = 32, p b 0.05 vs. 74.6% for [Ca2+]C,
Fig. 3I). Neither vector (Fig. 4C, D) nor nonspeciﬁc siRNA affected the
[Ca2+] signal in nucleoplasmor cytoplasm (Fig. 4E, F). Of note, the great-
er magnitude of [Ca2+] increase in nucleoplasm than the synchronous
or simultaneous one in cytoplasm may reﬂect the differences in the
buffering capabilities of the nucleus versus the cytosol.
Although the above results provide a clue for the participation of
STIM1 in [Ca2+]N signaling in HUVEC in addition to its well-known
role in SOCE, [Ca2+]N signal can be partially dependent on [Ca2+]C. To
completely reveal the novel role of STIM1, it was necessary to ﬁnd out
a situation under which the [Ca2+]N signal occurs independently of
[Ca2+]C. For this purpose, TG-treated HUVEC were exposed to extracel-
lular Ca2+ in a series of gradually decreased concentrations from 2.0 to
0.03 mM. Lowering extracellular Ca2+ concentration ([Ca2+]E) from
2.0 mM to 1.0 and 0.3 mM gradually decreased [Ca2+]N and [Ca2+]C in
a parallel way (Fig. 5A–C and F). Further lowering extracellular Ca2+
concentration to 0.1 and 0.03 mM further decreased [Ca2+]C; however,
it did not signiﬁcantly affect [Ca2+]N signal (Fig. 5D–F). Thus, 0.1 mM
[Ca2+]E was employed in the subsequent experiments as the condition
or setting tomonitor [Ca2+]C-independent [Ca2+]N signaling separately.
Of note, the above results did not imply that [Ca2+]C-independent
[Ca2+]N occurred only in the presence of 0.1 mM [Ca2+]E or below. In
the presence of normal or physiological [Ca2+]E of 2.0 mM, [Ca2+]C-
independent [Ca2+]N should also occur together with [Ca2+]C-
dependent [Ca2+]N. The selective buffering of [Ca2+]C elevation by
BAPTA signiﬁcantly inhibited but did not completely abolished
histamine-stimulated [Ca2+]N elevation in the presence of 2.0 mM
[Ca2+]E, which also indicated that [Ca2+]C-independent [Ca2+]N oc-
curred physiologically (Fig. S1).
The overexpression of wild STIM1 slightly increased [Ca2+]C and
[Ca2+]N (Fig. 6C–E). By contrast, the overexpression of mutated STIM1
greatly increased [Ca2+]C and [Ca2+]N under both 0.1 mM [Ca2+]E
([Ca2+]C-independent [Ca2+]N, Fig. 6F, G) and 2.0 mM [Ca2+]E (Fig. 6F
and H). Importantly, the overexpression of mutated STIM1 increased
[Ca2+]C-independent [Ca2+]N more profoundly than [Ca2+]C (changed
by ~128% for [Ca2+]N amplitude, p b 0.01 vs. ~73% for [Ca2+]C[Ca2+] responses. HUVECs untransfected as control (A) or transfected with vector (C),
onses in nucleoplasm and cytoplasm induced by thapsigargin (TG) in the absence (peak
ly monitored. The shRNA constructs simultaneously encoded GFP for identiﬁcation of
Normalized [Ca2+] responses (R2/R1%) in nucleoplasm and cytoplasm plotted against the
xperiments), vector (94 cells from 15 independent experiments), nonspeciﬁc shRNA (70
xperiments), respectively. The averaged inhibition of [Ca2+] signal in nucleoplasm and
Fig. 5. Cytoplasmic Ca2+-independent nucleoplasmic [Ca2+] responses. Fluo 3-loadedHUVECwere treated by 1 μM thapsigargin in Ca2+-free/EGTA buffer to deplete Ca2+ store(s), which
stimulated a large, transient increase in [Ca2+] in cytoplasm andnucleoplasm (R1), the subsequent application of 2.0 (A), 1.0 (B), 0.3 (C), 0.1 (D), and 0.03mMCa2+ (E) evoked an increase
in [Ca2+] in both cytoplasm and nucleoplasm (R2), respectively. Normalized [Ca2+] responses (R2/R1 ratio) in nucleoplasm and cytoplasm plotted against the extracellular Ca2+
concentrations were summarized and compared in F, showing that lowering extracellular Ca2+ concentration from 2.0 mM to 1.0 and 0.3 mM gradually decreased nucleoplasmic Ca2+
and cytoplasmic Ca2+ in a parallel way, further lowering extracellular Ca2+ concentration to 0.1 and 0.03 mM further decreased cytoplasmic Ca2+, however, did not further affect the
nucleoplasmic Ca2+ signal (96, 70, 50, 32, and 47 cells from at least 3 independent experiments for A, B, C, D, and E, respectively).
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in regulating [Ca2+]N signaling. The overexpression of mutated STIM1
also increased [Ca2+]N amplitude in the presence of 2.0 mM [Ca2+]E
(Fig. 6H), suggesting the contribution of [Ca2+]C-independent [Ca2+]N
regulation bymutated STIM1 to the overall level of [Ca2+]N under phys-
iological circumstances. The altered [Ca2+]C signal by the manipulation
ofmutated STIM1 expression suggests thatmutated STIM1 can also pro-
vide an additional role in SOCE, although this is much weaker than its
role in regulating [Ca2+]N. While the expression of STIM1 was knock-
down by shRNA, both 0.1 mM [Ca2+]E-dependent [Ca2+]N and 2.0 mM
[Ca2+]E-dependent [Ca2+]N as well as [Ca2+]C itself were inhibited
(Fig. 6I–K). The more profound inhibition of [Ca2+]N compared with
[Ca2+]C in 2.0 mM extracellular Ca2+ (Fig. 4I and Fig. 6K) was probably
due to the decreased levels of endogenouswild andmutated STIM1. The
inhibition of [Ca2+]C-independent [Ca2+]N by STIM1 knockdown
provides an additional evidence for the role of STIM1 in [Ca2+]N
signaling.
To further reveal the importance of mutated STIM1 in regulating
[Ca2+]N, HUVECswere isolated from three different donors. The relative
abundance of WT and mutated STIM1 mRNA as well as [Ca2+]C and
[Ca2+]N alterations stimulated by histamine in the presence of 2.0 mM
Ca2+ were monitored. Regression analysis revealed a good correlation
between [Ca2+]N amplitude and mutated STIM1 abundance (mutated
STIM1 mRNA = 1.00:1.33:2.44, R = 0.636, p b 0.01, Fig. 7I), whereas
no correlation between [Ca2+]N and wild STIM1 abundance was found
(WT STIM1mRNA=0.60:1.00:1.07, p=NS, Fig. 7G). Therewas no cor-
relation between [Ca2+]C amplitude and wild STIM1 abundance
(p N 0.01, Fig. 7F), indicating that the difference of wild-type STIM1
abundance among HUVECs from the donors was not sufﬁcient to affect
[Ca2+]C or the effect of wild STIM1 amongHUVECs from the donors was
possibly saturated. The difference of mutated STIM1 abundance did not
affect [Ca2+]C amplitude either (p N 0.05, Fig. 7H), further suggesting the
speciﬁc role of mutated STIM1 in regulating [Ca2+]N signaling.
To precisely characterize themechanism of STIM1 in [Ca2+]N signal-
ing in HUVECs, TG-induced [Ca2+]C and [Ca2+]N responses were evalu-
ated by inhibiting inositol (1,4,5)-trisphosphate(InsP3), ryanodine
receptors (RyRs), and nicotinic acid adenine dinucleotide phosphate
(NAADP) using heparin and XeC, ryanodine, or Ned-19, respectively.
Ryanodine signiﬁcantly decreased [Ca2+]N evoked by 0.1 mM extracel-
lular Ca2+ (91 cells from four independent experiments, p b 0.01 vs.
control) but did not affect [Ca2+]C under the same condition(Fig. S2H–J). Ned-19, the speciﬁc antagonist of NAADP receptor, signiﬁ-
cantly decreased [Ca2+]N evoked by 0.1mM extracellular Ca2+ (15 cells
from four independent experiments, p b 0.01 vs. control) but did not af-
fect [Ca2+]C under the same condition (Fig. S2K–M). Heparin or XeC
failed to affect [Ca2+]C or [Ca2+]N evoked by 0.1 mM extracellular
Ca2+ (72, 84 cells from 3 or 4 separate experiments, p=NS vs. control,
Fig. S2B–G). Heparin, XeC, or ryanodine did not affected [Ca2+]C or
[Ca2+]N evoked by 2.0 mM extracellular Ca2+. Ned-19 or a combination
of ryanodine and Ned-19, however, signiﬁcantly inhibited [Ca2+]N
evoked by 2.0 mM extracellular Ca2+ (Fig. S2N–P). Additionally, no ef-
fect of WT, mutated STIM1, or CREB inhibitor on RyR expression was
noted (Fig. S3). Taken together, the above results imply that mutated
STIM1-associated [Ca2+]N signaling occurs possibly through a RyRs
and NAADP-dependent mechanism.
3.5 STIM1 in [Ca2+]N-regulated transcription, gene expression, and tube
formation
To characterize the biological signiﬁcance of STIM1-participated
[Ca2+]N signaling, agonist-stimulated [Ca2+]C, and [Ca2+]N signaling,
the activity of cyclic-AMP-response element binding protein(CREB)
and CREB-regulatedmatrixmetalloproteinase-2 (MMP-2) gene expres-
sion, the [Ca2+]N-dependent processes were evaluated in HUVECs with
manipulated expression of STIM1. As shown in Fig. 8, histamine stimu-
lated both [Ca2+]C and [Ca2+]N oscillations, the former ones ceased at
~30 min after stimulation, whereas the later ones continued during
the experimental period (~60 min). Histamine-stimulated [Ca2+]N os-
cillations in the period of ~60 min in ~55% mutated STIM1-
overexpressed HUVECs, in ~21–26% control, vector, wild-type STIM1-
overexpressedHUVECs, vehicle, and CREB inhibitor-pretreatedHUVECs,
and in only ~12% STIM1-knockdownHUVECs (38, 28, 19, 34, 17, 22, and
17 cells showing [Ca2+]C oscillations in response to histamine stimula-
tion from at least 3 separate experiments, respectively). The frequency
and the spike duration of the [Ca2+]N oscillations were not affected by
the manipulation of STIM1 expression or the treatment with KG501,
the CREB inhibitor (Fig. 8H). However, the overexpression of mutated
STIM1, not wild-type STIM1, signiﬁcantly increased, whereas STIM1
knockdown obviously attenuated the amplitude of histamine-
stimulated [Ca2+]N oscillations (those lasted for ~60 min, Fig. 8I,
*p b 0.05). HUVECs with the above-mentioned manipulated STIM1 ex-
pressions were stimulated by 1 μM histamine in 2.0 mM extracellular
Fig. 6. Effects of mutated STIM1 on thapsigargin-induced cytoplasmic and nucleoplasmic [Ca2+] responses. Western blotting and densimetric analysis of STIM1 (n=3 for each, *p b 0.01,
A). HUVECs untransfected as control (B), transfected with wild STIM1 overexpression vector (C–E), mutated STIM1 overexpression vector (F-H), or STIM1 knockdown shRNA (I-K) were
loaded with Fluo-3. [Ca2+] responses in nucleoplasm and cytoplasm induced by thapsigargin (TG) in the absence (peak as R1) and then the presence of 0.1 (peak as R2) and 2.0 mM
extracellular Ca2+ (peak as R3) were continuously monitored. All the above constructs simultaneously encoded GFP for identiﬁcation of transfected HUVECs individually. [Ca2+]
responses in nucleoplasm and cytoplasm were normalized as R2/R1 (D, G, and J, y-axis left) and R3/R1 (E, H, and K, y-axis left) for 0.1 and 2.0 mM extracellular Ca2+, respectively. The
fold changes of the Ca2+ amplitude of transfected HUVEC comparedwith control were also shown (blue, y-axis right). n=25, 21, 28, and 47 cells from 3 separate experiments for control
(B), wild-type STIM1 overexpression (C-E), mutated STIM1 overexpression (F-H), and STIM1 knockdown (I-K), respectively.
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STIM1 expression did not signiﬁcantly affect the 30 min histamine
stimulation-activated CREB activities (Fig. 8J). The 60 min stimulation
of histamine-activated CREB activities (Fig. 8K), MMP-2 mRNA expres-
sions (Fig. 8L), and tube forming (Fig. 8M) were signiﬁcantly augment-
ed inmutated STIM1-overexpressedHUVECs or obviously attenuated in
STIM1 knockdown or CREB inhibitor-treated HUVECs as compared to
other preparations (fold of control, *p b 0.05). The mutated STIM1
mRNA and MMP-2 protein expression were signiﬁcantly higher in na-
tive HUVECs isolated from the patients with gestational hypertension
than control (Fig. 8N) and correlated with systolic blood pressure
(Fig. 8O).4. Discussion
We found a translocation of endogenous STIM1 to nuclear mem-
brane upon Ca2+ store(s) depletion in endothelial cells and then identi-
ﬁed a single point mutation in endothelial STIM1, a T-to-C transition at
nucleotide 44 that resulted in a Leu→ Pro substitution at position 15 in
the signal peptide. Ca2+ store(s) depletion stimulated a rapid transloca-
tion of mutated STIM1-GFP from the cytoplasm to cytoplasmic mem-
brane and nuclear membrane and the subsequent sliding along
nuclear membrane, whereas only the translocation from the cytoplasm
to cytoplasmic membranewas noted inWT STIM1-GFP under the same
condition, indicating that the new phenomenon of nuclear membrane
Fig. 7. Effects of wild-type and mutated STIM1 mRNA abundance on histamine-triggered cytoplasmic and nucleoplasmic [Ca2+] responses in HUVECs from different donors.
Representative ﬂuorescence tracing of real-time PCR showing speciﬁc ampliﬁcation of wild (A) and mutated STIM1 mRNA (B) using speciﬁc primers, respectively. Quantiﬁcation of
GAPDH (C), wild (D), and mutated STIM1 (E) mRNA levels in HUVECs from three donors by real-time PCR. Regression analysis between cytoplasmic and nucleoplasmic [Ca2+]
amplitude and wild-type or mutated STIM1 abundance (ratio representing relative levels normalized to one donor, F–I). Ca2+ signal were obtained from 1 μM histamine-stimulated
HUVECs when 2.0 mM extracellular Ca2+ was present (31, 30, and 50 HUVECs for the donor, respectively).
Fig. 8. Effects of mutated STIM1 on histamine-triggered cytoplasmic and nucleoplasmic [Ca2+] oscillations, CREB activity, and MMP-2 gene expression. HUVECs untransfected as control
(A), transfectedwith an empty vector (B), WT STIM1 overexpression vector (C), mutated STIM1 overexpression vector (D), STIM1 knockdown shRNA (E), vehicle (F), or KG501 (G)were
loaded with Fluo-3. [Ca2+] responses in nucleoplasm and cytoplasm induced by 1 μM histamine when 2.0 mM extracellular Ca2+ was present were continuously monitored. All the
constructs simultaneously encoded GFP for identiﬁcation of transfected HUVECs individually. The frequency, spike duration, and amplitude of cytoplasmic [Ca2+] oscillations-
independent nucleoplasmic [Ca2+] oscillations were summarized and compared (H and I). Endogenous CREB activity in HUVECs with manipulated STIM1 expressions exposed to 1 μM
histamine when 2.0 mM extracellular Ca2+ was present for 30 (J) and 60 min (K), MMP-2 mRNA expression (L), and tube forming (M) from HUVECs after a 60 min of 1 μM histamine
stimulation(n= 3 for each) were shown. A representative and quantitative summary of mutated STIM1mRNA (N, y-axis left) and MMP-2 expression level (N, y-axis right) from freshly
isolatedHUVECs of control subjects and patientswith gestational hypertension (GH)were presented. The correlation between systolic blood pressure andmutated STIM1mRNA orMMP-
2 expression level of pregnant subjects was summarized (O, p b 0.05 for both).
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627F. Chen et al. / Biochimica et Biophysica Acta 1863 (2016) 617–629translocation of endothelial STIM1 was possibly due to the amino acid
substitution. To further explorewhether STIM1 is localized in the nucle-
ar membrane of native HUVECs, we also performed mass spectrometry
(MS) analysis and ourMSwith nuclearmembrane prepared fromnativeHUVECs indicated that STIM1 was indeed among the N1700
protein(s) identiﬁed to express in the nuclear membrane of this type
of cells (Supplementary Table 1). The successful sample preparation
was conﬁrmed by the expression of LAP2, LMNA, and NUMA1, the
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ed in the same sample prepared form the native HUVECs (also in Sup-
plementary Table 1). Due to the technical limitation of MS, the results
unfortunately cannot distinguish whether the detected expression of
STIM1 is a wild type or mutated one. Of note, an STIM1 partner
translocated to the nuclear envelope on Ca2+ store(s) depletion [37].
STIM1has been documented to be important in Ca2+ signaling inde-
pendent on SOCE [6,12,13,38]. By contrast to well-studied and better-
characterized [Ca2+]C signaling, [Ca2+]N signaling has been a controver-
sial battleﬁeld for many years. Previously, [Ca2+]N levels were believed
to depend on [Ca2+]C transients. Recently, however, [Ca2+]N and
[Ca2+]C signaling have been shown to be regulated independently
[14–22].
Both [Ca2+]N and [Ca2+]C were attenuated by STIM1-knockdown
(Figs. 4 and 6). The attenuated [Ca2+]C signal can be due to its role in
SOCE. However, the more profound inhibition of [Ca2+]N (also in
Figs. 4 and 6) cannot be solely or arbitrarily explained by the possible
dependence of [Ca2+]N on [Ca2+]C. The changes of [Ca2+]N in 0.1 and
0.03 mM extracellular Ca2+ was found to be independent on [Ca2+]C
(Fig. 5). Themore profound inhibition of [Ca2+]N by siRNAmay be relat-
ed with the additional and the [Ca2+]C-independent regulation of
[Ca2+]N by mutated STIM1. The occurrence of [Ca2+]C-independent
[Ca2+]N signaling reported here agrees with previous studies in several
types of cells using different protocols [14,15,16,17,18,19,20,21,22]. In
the overexpression of mutated, no WT STIM1 was found to increase
[Ca2+]C-independent [Ca2+]N signal (Fig. 6), suggesting a particular
role of mutated STIM1 in [Ca2+]N signaling. The signiﬁcant correlation
between [Ca2+]N amplitude and mutated STIM1 abundance in native
HUVECs from different donors (Fig. 7) provided an additional, (patho-
)physiological-relevant evidence for the mutated STIM1 in regulating
[Ca2+]N signaling. Although these results indicate a possible role of the
mutated STIM1 in the control of [Ca2+]N, the involvement of themutat-
ed STIM1 in [Ca2+]C cannot be excluded in the current study since the
overexpression of mutated STIM1 also augmented [Ca2+]C in some ex-
tent (Fig. 6). The mutated STIM1 is involved in [Ca2+]C in a way proba-
bly different fromWT STIM1 since the overexpression of WT STIM1 did
not augmented [Ca2+]C in low extracellular Ca2+ (Fig. 6).
InsP3, ryanodine, and NAADP receptors have been claimed as prima-
ry candidates for releasing Ca2+ from the nuclear envelope [16], al-
though nicotinic acid adenine dinucleotide phosphate and cyclic ADP-
ribose may work through ryanodine receptors (RyRs)-dependent and
-independent way [14,15,16,22]. The inhibition of RyRs and NAADP re-
ceptors, not InsP3Rs, signiﬁcantly decreased [Ca2+]C-independent
[Ca2+]N evoked by agonist (Fig. S2), suggesting a mechanistic role of
RyRs and NAADP receptors in mediating mutated STIM1-regulated
[Ca2+]N signaling. It is noted that STIM1 did not alter the expression of
RyRs (Fig. S3).
[Ca2+]N signaling has been reported to be critical in the regulation of
many downstream cellular events [14,15,21,22,39,40]. It was found that
suppression of [Ca2+]N, but not [Ca2+]C, inhibited epidermal growth
factor-induced transactivation of Elk-1 [41]. The functional signiﬁcance
of STIM1-associated [Ca2+]N signaling in HUVEC was explored by mea-
suring CREB activity and gene expression of MMP-2, which has been
shown to be regulated by [Ca2+]N-activated CREB pathway [42,43,44].
Endothelial tube forming, a process critically controlled by MMP-2 [45,
46], was also regulated by mutated STIM1 (Fig. 8). Our results about
[Ca2+]N-regulated CREB activity and gene expression are in consistence
with previous studies showing that [Ca2+]N and [Ca2+]C distinctly con-
trol gene expression and an increase in [Ca2+]N controls Ca2+-activated
gene expression mediated by CREB [42,43,44,39]. MMP-2 governs fun-
damental functions of a variety of cells including endothelium [45,46,
47]. The abundance of mutated STIM1 mRNA and the MMP-2 expres-
sion were found to be higher in native HUVECs isolated from the pa-
tients with gestational hypertension than controls and were
signiﬁcantly correlatedwith blood pressure (Fig. 8), suggesting a poten-
tial importance of mutated STIM1 in the pathobiology of hypertensivedisorders of pregnancy through a [Ca2+]N signaling-associated MMP-2
mechanism. In support of this, the plasmaMMP-2 level, not its genotype
or haplotypes, was reported to link with gestational hypertension [48].
The cause–effect relationship between mutated STIM1-altered
downstream events (including CREB activity, MMP-2 expression, and
endothelial tube forming) and its nuclear membrane translocation and
[Ca2+]N regulation would be possibly further strengthened by
employing an STIM1 variant with the single mutation, however, with-
out nuclear membrane translocation and the regulation of [Ca2+]N sig-
nal, e.g., overexpressing the mutated STIM1 lacking the amino acids
233–685, which is essential for STIM1 translocation [11].
Taken together, our results indicated that STIM1 can not only regu-
late cytoplasmic Ca2+ signaling through itswell-known role in extracel-
lular Ca2+ inﬂuxbut also independently strengthen nucleoplasmic Ca2+
signaling by orchestratingwith its Leu to Promutant partner and subse-
quently enhance the cAMP responsive element binding protein activa-
tion, matrix metalloproteinase-2 gene expression, and endothelial
tube forming and may be involved in the pathohysiological
mechanism(s) of gestational hypertension.
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